Rose Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

FDA Eyeing Study On Cosmetic Hair-Care/Hair-Loss Link

Executive Summary

Interested parties capable of conducting in vivo and in vitro tests "to study alopecia that may be associated with the use of commercially available cosmetic hair products and individual ingredients in these products" must respond to FDA's Sources Sought Notice by Feb. 26.

Advertisement

Related Content

Monat Sues Former Sales Rep For 'Libelous' WEN-Like Allegations
Clairol Hair-Dye Suit Cites PPD Use, ‘Inadequate’ Home Sensitization Test
L’Oreal Hair-Relaxer Class Action A Far Cry From WEN, Or Next Plaintiff Payout?
Cosmetics Adverse Events Under Spotlight In FDA Transparency Push
Sen. Alexander Questions FDA's Slow Response To WEN Complaints
FDA Seeks Info From Injured WEN Users, Docs As Investigation Continues

Topics

Related Companies

Advertisement
UsernamePublicRestriction

Register

RS121458

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel